Health
Report finds brain tumour patients at NHS trust received years of unnecessary chemotherapy
· Updated
Coverage
3 reports · 1 in Arabic, 2 in English · over 8 hours
A Royal College of Physicians review of 20 cases at University Hospitals Coventry and Warwickshire found patients were misdiagnosed and kept on chemotherapy beyond standard courses.
- The review, released on Wednesday, graded 15 of the 20 cases as unsatisfactory care and five as requiring improvement.
- The report found 83 patients received extended temozolomide treatment between 2017 and 2023, beyond the standard six-month course.
- Chief executive Andy Hardy and chair Sue Noyes apologised, saying "we let you down" and that failures fell below standards patients deserve.
- Becky Jones, who received more than 100 cycles over 11 years for a tumour she did not have, called for a national public inquiry.
- More than 40 patients affected by the misdiagnoses have taken legal action against the University Hospitals Coventry and Warwickshire trust.
- The trust expanded its review to cover patients treated since 2005 and all living patients who received more than 12 chemotherapy cycles.
- The trust pledged tighter oversight of clinical decisions and of error reporting following the review.

